Ellevest Inc’s Werewolf Therapeutics HOWL Stock Holding History

Ellevest Inc’s Portfolio HOWL Stock Details HOWL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-12	Closed	–	–	1898
2022 Q3	$0	Sell	12 -19	-61%	-$103	﹤0.01%	1705
2022 Q2	$0	Buy	+31	New	+$141	﹤0.01%	1512

Other funds holding HOWL

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return

Ellevest Inc's HOWL Position: Q4 2022 in Review

Ellevest Inc sold out of Werewolf Therapeutics (HOWL) in Q4 2022, closing a stake of 12 shares.

Ellevest Inc first reported a position in HOWL in Q2 2022 and held it in 2 quarters. The position peaked at $0 in Q3 2022. 39 funds tracked by Wall St. Rank hold HOWL as of Q4 2022.

Ellevest Inc reported no remaining Werewolf Therapeutics position as of Q4 2022 after selling out during the quarter.
Ellevest Inc sold 12 Werewolf Therapeutics shares in Q4 2022.
Ellevest Inc first reported a position in Werewolf Therapeutics in Q2 2022 and held it in 2 quarters.
Ellevest Inc's Werewolf Therapeutics position peaked at $0 in Q3 2022.
39 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q4 2022.

Based on Ellevest Inc's 13F filing for Q4 2022, filed 3 Feb 2023.